Author

C. Kaas Frich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. N. Zelikin· 1 shared B. Schiott· 1 shared C. Lunaberg· 1 shared J. Jakobsen· 1 shared J. Muench· 1 shared L. K. Ladefoged· 1 shared M. Hayn· 1 shared M. Jarlstad Olesen· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. N. Zelikin

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivJan 12, 2022

Potentiation of drug toxicity through virus latency reversal promotes preferential elimination of HIV infected cells

T. Truong, M. Hayn, C. Kaas Frich…·A. N. Zelikin

The paper demonstrates that latency reversal enhances the toxicity of HIV protease-activated toxins, preferentially eliminating HIV-infected cells in mixed populations.

DOI 10.1002/adtp.202200113

humanexperimental assay

𝕏 PostBluesky